Francesco Passamonti

A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders

Róbert Královics, Francesco Passamonti, Andreas Buser et al. · New England Journal of Medicine · 2005 · 3.5K citations · Full text

Life Sciences, Genetics, Hematology +15

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian et al. · Blood · 2022 · 2.7K citations · Full text

Medicine, Hematology, Oncology +17

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

Francisco Cervantes, Brigitte Dupriez, Arturo Pereira et al. · Blood · 2008 · 1.2K citations · Full text

Medicine, Hematology, Pathology +16

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

Naseema Gangat, Domenica Caramazza, Rakhee Vaidya et al. · Journal of Clinical Oncology · 2010 · 1K citations · Full text

Medicine, Hematology, Clinical Classification Systems +16

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi et al. · Blood · 2009 · 968 citations · Full text

Medicine, Biostatistics, Oncology +14